IberiaBank’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-11,778
Closed -$1.17M 232
2019
Q3
$1.17M Sell
11,778
-734
-6% -$69.7K 0.14% 113
2019
Q2
$1.16M Buy
12,512
+493
+4% +$46.8K 0.13% 124
2019
Q1
$1.13M Buy
12,019
+121
+1% +$10.6K 0.13% 129
2018
Q4
$763K Sell
11,898
-25
-0.2% -$1.84K 0.1% 149
2018
Q3
$1.07M Sell
11,923
-106
-0.9% -$9.37K 0.13% 139
2018
Q2
$955K Sell
12,029
-1,997
-14% -$166K 0.17% 139
2018
Q1
$1.25M Sell
14,026
-26,142
-65% -$2.51M 0.25% 120
2017
Q4
$4.19M Buy
40,168
+11,859
+42% +$1.34M 0.66% 50
2017
Q3
$3.98M Buy
28,309
+17,408
+160% +$2.37M 0.66% 47
2017
Q2
$1.42M Buy
10,901
+764
+8% +$93.6K 0.42% 84
2017
Q1
$1.26M Buy
10,137
+6,885
+212% +$824K 0.4% 82
2016
Q4
$376K Buy
+3,252
New +$362K 0.14% 117
2016
Q1
Sell
-2,550
Closed -$305K 180
2015
Q4
$305K Buy
2,550
+271
+12% +$31.4K 0.14% 116
2015
Q3
$247K Buy
2,279
+71
+3% +$8.81K 0.13% 130
2015
Q2
$256K Buy
+2,208
New +$252K 0.11% 147

Other funds holding CELG

IberiaBank's CELG Position: Q4 2019 in Review

IberiaBank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 11,778 shares — an estimated $1.17M sold.

IberiaBank first reported a position in CELG in Q2 2015 and held it in 15 quarters. The position peaked at $4.19M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • IberiaBank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • IberiaBank sold 11,778 Celgene Corp shares in Q4 2019, an estimated $1.17M.
  • IberiaBank first reported a position in Celgene Corp in Q2 2015 and held it in 15 quarters.
  • IberiaBank's Celgene Corp position peaked at $4.19M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on IberiaBank's 13F filing for Q4 2019, filed 31 Jan 2020.